[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE518829T1 - Verfahren zur herstellung von escitalopram - Google Patents

Verfahren zur herstellung von escitalopram

Info

Publication number
ATE518829T1
ATE518829T1 AT08801398T AT08801398T ATE518829T1 AT E518829 T1 ATE518829 T1 AT E518829T1 AT 08801398 T AT08801398 T AT 08801398T AT 08801398 T AT08801398 T AT 08801398T AT E518829 T1 ATE518829 T1 AT E518829T1
Authority
AT
Austria
Prior art keywords
escitalopram
producing escitalopram
producing
Prior art date
Application number
AT08801398T
Other languages
English (en)
Inventor
Faveri Carla De
Florian Anton Martin Huber
Robert James Dancer
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE518829(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE518829T1 publication Critical patent/ATE518829T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08801398T 2007-09-11 2008-09-10 Verfahren zur herstellung von escitalopram ATE518829T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200701314 2007-09-11
PCT/DK2008/050222 WO2009033488A1 (en) 2007-09-11 2008-09-10 Method for manufacture of escitalopram

Publications (1)

Publication Number Publication Date
ATE518829T1 true ATE518829T1 (de) 2011-08-15

Family

ID=39735675

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08801398T ATE518829T1 (de) 2007-09-11 2008-09-10 Verfahren zur herstellung von escitalopram
AT0048708U AT10984U1 (de) 2007-09-11 2008-09-11 Verfahren zur herstellung von escitalopram

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT0048708U AT10984U1 (de) 2007-09-11 2008-09-11 Verfahren zur herstellung von escitalopram

Country Status (52)

Country Link
EP (2) EP2397461A1 (de)
JP (1) JP4966933B2 (de)
KR (1) KR101054224B1 (de)
CN (1) CN101386583A (de)
AR (2) AR068174A1 (de)
AT (2) ATE518829T1 (de)
AU (1) AU2008212055C1 (de)
BE (1) BE1017548A6 (de)
BG (1) BG110206A (de)
BR (1) BRPI0804121B1 (de)
CA (1) CA2638499C (de)
CH (1) CH697885B1 (de)
CL (1) CL2008002686A1 (de)
CO (1) CO6140012A1 (de)
CY (2) CY2600B1 (de)
CZ (1) CZ2008537A3 (de)
DE (1) DE102008046530A1 (de)
DK (2) DK2061753T3 (de)
EA (1) EA012787B1 (de)
EE (1) EE00864U1 (de)
ES (2) ES2334875B1 (de)
FI (1) FI121570B (de)
FR (1) FR2920766A1 (de)
GB (1) GB2448848B (de)
GR (1) GR1006595B (de)
HR (2) HRP20080425A2 (de)
HU (1) HUP0800549A2 (de)
IE (1) IES20080708A2 (de)
IL (1) IL193845A (de)
IS (1) IS8758A (de)
LT (1) LT5577B (de)
LU (1) LU91479B1 (de)
LV (1) LV13813B (de)
ME (1) ME00176B (de)
MX (1) MX2008011451A (de)
MY (1) MY144210A (de)
NL (1) NL2001953C2 (de)
NO (1) NO20083756L (de)
NZ (1) NZ570884A (de)
PL (2) PL386026A1 (de)
PT (2) PT104169A (de)
RO (1) RO125301A2 (de)
RS (2) RS20080401A (de)
SE (1) SE533041C2 (de)
SG (1) SG151195A1 (de)
SI (2) SI22567A2 (de)
SK (1) SK500302008A3 (de)
TR (2) TR200907629A2 (de)
TW (1) TWI391383B (de)
UA (2) UA43461U (de)
WO (1) WO2009033488A1 (de)
ZA (1) ZA200807753B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1987016A1 (de) 2005-07-27 2008-11-05 Aurobindo Pharma Limited Verbessertes verfahren zur herstellung von escitalopram
CN102796065A (zh) * 2011-05-27 2012-11-28 江苏豪森医药集团连云港宏创医药有限公司 一种制备光学纯度高的艾司西酞普兰的方法
CN104119240A (zh) * 2013-04-23 2014-10-29 中国人民解放军军事医学科学院毒物药物研究所 (S)-(-)-α-甲胺基苯丙酮的制备方法
CN103497145B (zh) * 2013-10-10 2016-01-27 南昌大学 一种光学纯多奈哌齐的制备工艺
CN104119248A (zh) * 2014-08-08 2014-10-29 广东东阳光药业有限公司 S-西酞普兰的制备方法
ES2881105T3 (es) 2014-11-14 2021-11-26 Zhejiang Huahai Pharm Co Ltd Método para la resolución del producto intermedio de citalopram 5-cianodiol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
AR034612A1 (es) 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
IS7239A (is) * 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
PL207847B1 (pl) 2002-12-23 2011-02-28 Lundbeck & Co As H Sposób wytwarzania racemicznego 4-[4-(dimetyloamino)-1-(4'-fluorofenylo)-1- hydroksybutylo]-3-(hydroksymetylo)-benzonitrylu) i /lub R-lub S-4-[4-(dimetyloamino)-1-(4'-fluorofenylo)-1-hydroksybutylo]-3-( hydroksymetylo)- benzonitrylu) i sposób wytwarzania racemicznego citalopramu, R-citalopramu i/lub S-citalopramu
AU2003242990A1 (en) * 2003-01-17 2004-08-13 Pulla Reddy Muddasani Processes for the preparation of escitalopram and its precursor
US20090018351A1 (en) * 2003-11-12 2009-01-15 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
EP1877394A1 (de) * 2005-04-04 2008-01-16 Jubilant Organosys Limited Verfahren zur herstellung von escitalopram oder seinen säureadditionssalzen
EP1987016A1 (de) * 2005-07-27 2008-11-05 Aurobindo Pharma Limited Verbessertes verfahren zur herstellung von escitalopram

Also Published As

Publication number Publication date
CY2600B1 (en) 2010-03-03
AR108885A2 (es) 2018-10-03
TWI391383B (zh) 2013-04-01
TR200907629A2 (tr) 2009-11-23
ES2334875A1 (es) 2010-03-16
SE0801929L (sv) 2009-03-12
LV13813B (en) 2008-11-20
FI20085807A0 (fi) 2008-08-29
FI20085807A (fi) 2009-03-12
BRPI0804121B1 (pt) 2022-04-12
LT2008068A (en) 2009-03-25
GB0815773D0 (en) 2008-10-08
MEP10108A (en) 2010-10-10
SE533041C2 (sv) 2010-06-15
EA012787B1 (ru) 2009-12-30
JP2009149600A (ja) 2009-07-09
AU2008212055A1 (en) 2009-03-26
DE102008046530A1 (de) 2009-03-19
CN101386583A (zh) 2009-03-18
UA41919U (uk) 2009-06-10
ES2368294T3 (es) 2011-11-16
EP2061753A1 (de) 2009-05-27
MX2008011451A (es) 2009-03-10
GR20080100581A (el) 2009-04-30
HRP20080425A2 (hr) 2010-04-30
PT2061753E (pt) 2011-09-14
HUP0800549A2 (en) 2009-03-02
GB2448848A (en) 2008-10-29
RS51909B (en) 2012-02-29
ES2334875B1 (es) 2010-10-27
ME00176B (me) 2011-02-10
IS8758A (is) 2009-03-12
EA200801797A2 (ru) 2008-12-30
GB2448848B (en) 2011-01-26
EP2397461A1 (de) 2011-12-21
IES20080708A2 (en) 2009-03-18
KR101054224B1 (ko) 2011-08-08
ZA200807753B (en) 2009-04-29
KR20090027185A (ko) 2009-03-16
AU2008212055B2 (en) 2010-08-12
EP2061753B1 (de) 2011-08-03
HRP20110636T1 (hr) 2011-10-31
SI22567A2 (sl) 2008-12-31
BRPI0804121A2 (pt) 2009-09-29
PT104169A (pt) 2009-02-02
HU0800549D0 (en) 2008-10-28
SK500302008A3 (sk) 2009-04-06
CL2008002686A1 (es) 2009-01-02
BRPI0804121A8 (pt) 2021-04-13
BE1017548A6 (fr) 2008-11-04
LT5577B (lt) 2009-06-25
CY1111924T1 (el) 2015-11-04
GR1006595B (el) 2009-11-16
PL386026A1 (pl) 2009-02-16
DK200801265A (en) 2009-03-12
BG110206A (en) 2009-03-31
PL2061753T3 (pl) 2011-12-30
TR200806903A2 (tr) 2009-03-23
UA43461U (uk) 2009-08-25
SG151195A1 (en) 2009-04-30
CZ2008537A3 (cs) 2009-03-18
NL2001953A1 (nl) 2008-12-22
CA2638499A1 (en) 2008-11-21
DK177075B1 (da) 2011-06-14
NL2001953C2 (en) 2009-05-07
CO6140012A1 (es) 2010-03-19
EA200801797A3 (ru) 2009-02-27
AT10984U1 (de) 2010-02-15
CA2638499C (en) 2010-09-28
TW200906814A (en) 2009-02-16
RS20080401A (en) 2010-03-02
MY144210A (en) 2011-08-15
CH697885B1 (de) 2009-03-13
AU2008212055C1 (en) 2011-06-02
NZ570884A (en) 2010-03-26
LU91479B1 (fr) 2010-03-11
NO20083756L (no) 2009-03-12
EE00864U1 (et) 2009-10-15
SI2061753T1 (sl) 2011-10-28
DK2061753T3 (da) 2011-09-26
WO2009033488A1 (en) 2009-03-19
FI121570B (fi) 2011-01-14
RO125301A2 (ro) 2010-03-30
FR2920766A1 (fr) 2009-03-13
JP4966933B2 (ja) 2012-07-04
AR068174A1 (es) 2009-11-11
IL193845A (en) 2011-03-31

Similar Documents

Publication Publication Date Title
ATE455105T1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
ATE529527T1 (de) Verfahren zur herstellung von alkoholen
ATE516362T1 (de) Verfahren zur herstellung von biodiesel
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
ATE522488T1 (de) Verfahren zur herstellung von 1,2-dichlorethan
ATE516816T1 (de) Verfahren zur herstellung von impfstoffen
DE602006015090D1 (de) Verfahren zur herstellung von gezielt durchlässigen laminaten
ATE535568T1 (de) Verfahren zur herstellung von polyethylenzusammensetzungen
ATE554658T1 (de) Verfahren zur herstellung von blatttee
ATE544086T1 (de) Verfahren zur herstellung von kontaktlinsen
ATE475728T1 (de) Verfahren zur kontinuierlichen herstellung von kohlenstofffasern
ATE518847T1 (de) Verfahren zur herstellung von betamimetika
DE602007001585D1 (de) Verfahren zur herstellung von kunstlatex
ATE523545T1 (de) Verfahren zur herstellung von polyamid
ATE489015T1 (de) Verfahren zur herstellung von verschlüssen
ATE548345T1 (de) Verfahren zur herstellung von agomelatin
ATE524426T1 (de) Verfahren zur herstellung von 1,2-dichlorethan
DE502006001281D1 (de) Verfahren zur herstellung substituierter biphenyle
ATE542808T1 (de) Verfahren zur herstellung von epichlorydrin aus glyzerin
ATE546436T1 (de) Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE523483T1 (de) Verfahren zur herstellung von betainen
ATE540585T1 (de) Verfahren zur herstellung von tomatenpaste

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2061753

Country of ref document: EP